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Abstract
In spite of its highly immunogenic properties, Mycobacterium tuberculosis (Mtb) establishes persistent infection in otherwise
healthy individuals, making it one of the most widespread and deadly human pathogens. Mtb’s prolonged survival may
reflect production of microbial factors that prevent even more vigorous immunity (quantitative effect) or that divert the
immune response to a non-sterilizing mode (qualitative effect). Disruption of Mtb genes has produced a list of several dozen
candidate immunomodulatory factors. Here we used robotic fluorescence microscopy to screen 10,100 loss-of-function
transposon mutants of Mtb for their impact on the expression of promoter-reporter constructs for 12 host immune
response genes in a mouse macrophage cell line. The screen identified 364 candidate immunoregulatory genes. To illustrate
the utility of the candidate list, we confirmed the impact of 35 Mtb mutant strains on expression of endogenous immune
response genes in primary macrophages. Detailed analysis focused on a strain of Mtb in which a transposon disrupts
Rv0431, a gene encoding a conserved protein of unknown function. This mutant elicited much more macrophage TNFa, IL-
12p40 and IL-6 in vitro than wild type Mtb, and was attenuated in the mouse. The mutant list provides a platform for
exploring the immunobiology of tuberculosis, for example, by combining immunoregulatory mutations in a candidate
vaccine strain.
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Introduction
Mtb is one of the most potent admixtures of antigens and
adjuvants known. In the laboratory, heat-killed Mtb emulsified in
oil and water (Freund’s complete adjuvant) helps elicit high-titer
antibodies in animal models. Infection by Mtb elicits robust and
long-lasting T and B cell responses to numerous Mtb antigens.
Human T-cell responses to Mtb are so vigorous that injection of
the dead bacillus into an already infected individual leads to
inflammation-mediated tissue necrosis, a response called the Koch
phenomenon [1].
Yet human immunity frequently fails to eradicate Mtb infection
and an estimated one-third of the global population is latently
infected for life. Of these, 5–10% with no known impairment of
immunity will go on to develop active tuberculosis and infect an
average of 10 to 15 others [2]. When cured, such individuals
remain susceptible to re-infection and can again develop active
tuberculosis [3,4,5]. Mtb appears to have evolved to elicit an
immune response too weak to fully clear infection but paradox-
ically strong enough, in hosts with active disease, to liquefy lung
tissue and cause an infectious cough that allows transmission to
new individuals. These circumstances pose a major question for
immunobiology with significant implications for vaccinology: How
does Mtb sculpt the host immune response to be quantitatively
large but often qualitatively inadequate?
Answering this question requires a better understanding of how
Mtb modulates immunity. Murine models of infection recapitulate
a number of key features of the human disease and allow the use of
genetically modified bacteria and hosts to identify determinants of
pathogenicity and susceptibility. In one such model, genetically
resistant mice inhale small numbers of bacilli that are phagocy-
tosed by macrophages in the pulmonary alveoli. The bacilli are
transported into the interstitium and taken up by resident or
recruited monocytes, macrophages, dendritic cells and neutrophils
[6]. Dendritic cells carry Mtb to draining lymph nodes, where
naı ¨ve T cells are activated. Before, during or despite T cell
activation, the bacteria replicate and escape into the efferent
lymph, which carries them to the bloodstream for dissemination
throughout the body, where most are taken up by macrophages.
In people, disease can emerge at any time in any site, but most
often appears years later in the lung.
Following priming and clonal expansion in lymph nodes, mouse
Mtb-specific T cells traffic to the lung at ,2–3 weeks post-
infection [7,8,9]. The onset of a Th1-dominated immune response
is marked by elevation of transcripts for IL-2, IL-12p40, IFNc,
TNFa and iNOS by 2 to 3 orders of magnitude [10,11].
Cytokines, in particular IFNc, synergize with products of Mtb to
activate infected macrophages [12]. These events coincide with
and are required for the abrupt cessation in bacterial outgrowth at
,3 weeks post-infection, whereupon replication and death rates
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near steady-state levels [13]. Nonetheless, inflammation escalates
over many months until the mouse succumbs to respiratory
insufficiency [14].
Presumably, early innate responses shape the adaptive immune
response to Mtb. As a primary reservoir for Mtb in vivo,
macrophages are crucial for controlling bacterial growth but also
influence the function of other cells in the immune system,
including T- and B-lymphocytes [15,16]. Recent ‘‘forward
genetics’’ studies, aimed at identifying novel innate immunity
pathways and factors that modulate the host-pathogen interaction,
have unearthed essential roles for macrophage autophagy and
production of immunomodulatory lipids in controlling Mtb disease
[17,18,19]. We focused here on the early encounter of
macrophages with Mtb and included IFNc to model the influence
of NK cells and cd T cells that produce IFNc during the earliest
days of infection [20,21], as do early-arising ab T cells. The
literature describes the impact of several dozen Mtb genes or gene
products on early responses of macrophages [22,23]. To expand
that knowledge we systematically assessed macrophage responses
to a large panel of loss-of-function mutants of Mtb.
Results
Development of Immunoreporter Macrophage Clones
To identify mutations in Mtb that lead to dysregulation of the
macrophage immune response, we screened a library of
10,100 Mtb mutants generated by transposon insertion mutagen-
esis. The same library has provided valuable hits in previous
screens [24,25]. With its dependence on expansion of mutant
clones, the library lacks inactivating mutations in genes essential
for in vitro growth, but otherwise it approaches the ideal of
representing loss of function mutations in most Mtb genes. Ideally
we would globally evaluate macrophage responses to each Mtb
mutant. However, safety constraints prevented us from generating
large volumes of infectious waste as would be required by
multiplexed ELISAs, and cost considerations precluded profiling
the macrophage transcriptome over 10,000 times. We therefore
limited the survey of the macrophage response to 12 host genes
whose expression could be detected microscopically using
fluorescent proteins as reporters.
We selected the host genes (Figure 1A) by the following criteria.
Pilot studies, in conjunction with published reports, confirmed that
expression of all 12 genes is transcriptionally regulated in mouse
macrophages in response to Mtb infection. Most are differentially
regulated during tuberculosis in human subjects and, with the
exception of Delta-4 and GITRL, targeted disruption of these
genes has been reported to impart a phenotype in mice with
experimental tuberculosis. Finally, they represented diverse
molecular classes – cytokines (TNF, IL-12p40, IL-6, IL-10, GM-
CSF), chemokines (RANTES, MCP-1), enzymes (iNOS, cycloox-
ygenase [COX] 2) and cell-surface co-stimulatory proteins (Delta-
4, CD40, GITRL) – with known roles in immune responses to
infection.
We stably transfected murine macrophage-like RAW 264.7 cells
with promoter-reporter constructs in which a promoter region of
each host immune-response gene drives expression of one of three
fluorescent proteins (AmCyan, DsRed or YFP) (Figure 1A). Each
of the twelve Immunoreporter (IR) macrophage lines was
subjected to clonal selection as follows. Unstimulated cells were
sorted by flow cytometry to isolate populations with minimal
resting fluorescence. From this group, cells that manifested high
levels of fluorescence when stimulated with IFNc (Figure 1B) were
expanded as individual clones. Finally, by microscopy (Figure S1)
we identified clones from each line that expressed homogeneously
low fluorescence at baseline and homogeneously high fluorescence
upon stimulation with IFNc or with LPS.
Stimulation of the IR macrophage cell clones with IFNc, Mtb,
or Mtb + IFNc confirmed that fluorescence induction (Figure 1C,
D) qualitatively reflected mRNA expression patterns for the native
gene products (Figure 1E). Further, fluorescence levels increased
along with increasing multiplicity of infection (MOI) (data not
shown). As a positive control for the ability of these IR clones to
resolve differences in stimulation induced by an Mtb mutant
compared to wild type (WT) Mtb, we infected the macrophages
with a mutant in mce1 that was reported to induce sub-normal
levels of IL-6 and MCP-1 [26]. Indeed, the mutant elicited lower
levels of fluorescence in the IL-6_YFP and MCP-1_DsRed IR
clones than WT Mtb, mirroring reduced secretion of IL-6 and
MCP-1 protein in wild-type RAW 264.7 cells (Figure S2A & S2B).
Primary Screen
Next we plated the 12 IR macrophage clones in 4 sets of 3. Thus,
each well of an assay plate contained one IR clone signaling the
expression of a given promoter via AmCyan, another announcing
the activity of a different promoter via DsRed and a third reporting
on yet another promoter via YFP. We infected each such well in
each set with one of the 10,100 Mtb mutants and monitored
alterations influorescenceinduction byautomated microscopy. The
use of pooled IR macrophage clones cut down the time and cost of
screening by a factor of 3. Based on pilot experiments that indicated
a better signal-to-noise ratio following IFNc-costimulation, we
reduced the burdenofscreening byanotherfactorof2 byomitting a
no-IFNc set and using IFNc-costimulation throughout. Because the
insertion of a transposon can affect Mtb biology, we reasoned that
the most relevant baseline was the average response induced by all
10,1000 mutants. We considered a mutant to be a candidate hit if it
elicited fluorescence levels differing from this average response to a
statistically robust extent (see below). Each fluorescence level was
characterized by its standardized residual (SR), a measure of the
number of standard deviations separating it from the mean
(Figure 2A).
Applying a cut-off of SR .2.0 or ,22.0 yielded 2712 unique
transposon mutants that induced altered fluorescence in one or
more of the 12 IR clones (Figure 2A–B). The majority (2492;
91.9%) of these Mtb mutants dysregulated responses in only one
or two of the IR clones (1885 and 607 Mtb mutants, respectively).
However, these numbers were not greater than expected by
chance, encouraging us to apply more robust statistical criteria
(Figure 2C). Application of a cut-off value of |SR| .3.5 reduced
the number of mutants that qualified as hits in one or two IR
clones to 99 (Table S1) and 46 (Table S2), respectively (quadrant I
of Figure 2B). Using the cutoff of |SR| .2.0, 210 mutants elicited
aberrant responses in three or more IR clones, while only 125 such
hits would be expected by chance. Differences between the
observed number of hits and the number expected by chance were
most dramatic for mutants that dysregulated four or more IR
clones (Figure 2C). The 210 mutants exceeding this level for at
least three IR clones could be further subdivided into 22 that
elicited highly aberrant responses in three or more IR lines
(average |SR| .3.5; quadrant II in Figure 2B and Table S3) and
188 that elicited moderately aberrant responses in three or more
IR lines (average 2.0, |SR| ,3.5; quadrant III in Figure 2B and
Table S4).
Secondary Screen
The Mtb mutants chosen for further study (see below) were
retested in each IR line in which aberrant responses were detected
Mycobacterial Immunoregulatory Genes
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15120Figure 1. Generation and Validation of Immunoreporter Macrophage Clones. (A) RAW 264.7 cells were transfected with constructs in
which the promoter of a host gene was used to drive expression of a fluorescent reporter protein. The promoter region and 59-UTR are specified
relative to the ‘‘ATG’’ start codon of each gene. (B) Stably transfected IR populations were sorted by FACS to isolate cells with low baseline
fluorescence (red box on left panel), expanded in vitro, then stimulated with IFNc. Cells that upregulated fluorescence (red box on right panel) were
sorted again to yield clonal, inducible IR macrophage clones. (C) IR macrophages expressing the promoter-reporter TNFa_AmCyan, CD40_DsRed, or
Mycobacterial Immunoregulatory Genes
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mutants in large-volume flasks to ensure their near-uniform
viability, endeavored to prepare single-cell suspensions to better
control the size of the infecting inoculum, performed 5–6
independent infections for each and compared responses to those
induced by WT Mtb rather than to the average response to all
COX2_YFP constructs were seeded together, then treated with WT Mtb (MOI ,10), IFNc, or both for 24 hrs. Fluorescence induction was assessed
using automated fluorescence microscopy in the three distinct wavelengths. The bottom row represents a digital overlay of the three top rows. (D)
Quantitation of (C) using Metamorph software. Data represent means 6 SD of numbers (n) of independent wells indicated. (E) WT RAW 264.7 cells
were treated as in C. At 8 hrs, gene induction was evaluated by qRT-PCR. Expression levels are relative to gapdh and are expressed as fold change
relative to treatment with medium. Data represent means 6 SD of triplicate wells.
doi:10.1371/journal.pone.0015120.g001
Figure 2. Results of the Primary Screen. (A) The SR of the response induced by each mutant, represented by points across the x-axis. Data points
are color-coded according to the IR line in which the response was measured. (B) Hits (y-axis), defined as mutants that induced responses with an
avg. |SR| .2, were stratified according to the number of IR clones they dysregulated (x-axis). Mutants were categorized into four groups: (I) those that
strongly dysregulated fluorescence (avg. |SR| .3.5) in only 1 or 2 IR clones; (II) those that strongly dysregulated fluorescence in more than 2 IR clones;
(III) those that moderately dysregulated fluorescence (avg. |SR| =2–3.5) in more than 2 IR clones; and (IV) those that moderately dysregulated
fluorescence in 1 or 2 IR clones. (C) The number of hits (|SR| .2) is depicted as a function of the number of IR clones dysregulated by each mutant.
The numbers expected by chance (black) are compared to the numbers observed in the primary screen (red). Divergence between the observed and
expected values was greatest when $4 IR clones were dysregulated.
doi:10.1371/journal.pone.0015120.g002
Mycobacterial Immunoregulatory Genes
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subset of 191 hits from the primary screen. These were arbitrarily
chosen without regard to quadrant. The following mutants were
carried forward into the secondary screen: 55 mutants represent-
ing 38% of those in quadrant I of Figure 2B; 10 representing 44%
of those in quadrant II; 66 representing 34% of those in quadrant
III; and 60 representing 2.6% of those in quadrant IV. Figures 3A
and 3B illustrate results for 4 hits identified in the primary screen.
In aggregate, 29% of the hits were verified in the secondary screen,
distributed as follows. 70% of the mutants tested from quadrant II
were verified to dysregulate reporter induction in one or more IR
clones. In contrast, the secondary screen confirmed only 25% and
Figure 3. Illustration of Hit Confirmation in the Secondary Screen. (A) GITRL_DsRed IR macrophages were infected with WT Mtb or mutants
identified in the primary screen (MOI ,10). Fluorescence induction was assessed at 24 hrs by automated fluorescence microscopy. Images from three
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rates that were comparable to those observed for mutants from
quadrant IV. These observations conformed to expectations for
false positives from statistical expectations according to the cut-off
values chosen and the number of IR clones dysregulated. Among
the false positives from the primary screen were 23 mutants that
were also false negatives in the primary screen in the sense that
they consistently exhibited altered fluorescence induction in the
secondary screen that was directionally opposite to that observed
in the primary screen. These mutants were carried forward as new
positives in the secondary screen.
Phenotypes of Mtb Mutants in Primary Macrophages and
Identification of Mutated Genes
The next set of studies put aside IR clones and promoter-
reporter constructs in favor of primary bone marrow-derived
macrophages and endogenous gene products. We measured
transcript levels by qRT-PCR for GM-CSF, GITRL, CD40,
COX2, and iNOS and secreted proteins by ELISA for IL-10,
RANTES, TNFa, IL-12p40, MCP-1 and IL-6. We tested
responses to 3 different MOIs for both WT and mutant strains
of Mtb in 3 independent experiments per mutant, used the
complete data sets to calculate a single value (‘‘fold change’’) for
the greater or lesser efficiency of each Mtb mutant in eliciting a
given response compared to WT Mtb, and calculated the statistical
significance of each fold change, as detailed in the Supplemental
Materials and Methods. In these experiments, we studied 53 of the
56 hits verified in the secondary screen. Figure 4 lists the 36 (68%)
of these Mtb mutants that elicited statistically significant fold-
change values in primary macrophages and were therefore
considered verified in the tertiary screen.
We were able to map the site of transposon insertion for 26 of
the 36 mutants that confirmed in the tertiary screen (Figure 4).
Table 1 lists the genes in which the transposon inserted, without
implying that the phenotype necessarily arises from loss of function
in the designated gene. To assign function it is necessary to
evaluate the possibility of polar effects of each insertion and to
complement each disrupted gene with a WT copy; such efforts are
beyond the scope of this initial study.
Phenotype of Mtb Tn:Rv0431
We selected one mutant for more extensive characterization of
its impact on the host-pathogen interaction. In Mtb Tn:Rv0431,
the transposon inserted between codon 121 and 122 of Rv0431,a
Figure 4. Summary of Host Responses in Mutant-Infected BMD Macrophages. Values represent the relative increase in the immune
response as a function of increasing MOI, as compared to the response induced by WT Mtb. Only responses that were statistically different from the
WT responses (p,0.05) are quantified. Responses were pooled from three independent experiments, each of which was evaluated over a range of
three distinct MOIs. Fold-change .2.0 highlighted in red, 1.4–2.0 in pink, 0.6–0.7 in light blue, and ,0.5 in dark blue. ‘‘x’’ means that the response
failed to meet statistical significance. Gene names are supplied for strains in which mapping of the insertion site was successful.
doi:10.1371/journal.pone.0015120.g004
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function. Southern analysis of genomic DNA from this mutant
confirmed a single transposon insertion site (data not shown).
Rv0431 is the second gene in a putative 5-gene operon that also
includes Rv0430, sodC, Rv0433, and Rv0434. The putative operon
is highly conserved in Mycobacteria and other members of the
Actinobacteria family, including Nocardia and Rhodococcus species
(Figure 5A). The only gene in the putative operon with an assigned
function is sodC, which encodes a membrane-tethered zinc/copper
superoxide dismutase.
In the secondary screen, Tn:Rv0431 induced higher levels of
fluorescence in all IR clones except the RANTES_AmCyan IR
line (Figure 5B), the IR clone that gave the fewest verifiable results.
We infected WT RAW 264.7 cells with Tn:Rv0431 or WT Mtb
and evaluated induction of nine of the native host genes using
qRT-PCR. Infection with Tn:Rv0431 resulted in greater expres-
sion of transcripts for IL-12p40, IL-6, Delta4, CD40, GM-CSF,
RANTES, TNFa and MCP-1, but not GITRL or iNOS, than
WT Mtb, both with (not shown) or without IFNc costimulation
(Figure 5C). Results were similar at the protein level for the three
products tested by ELISA (IL-6, MCP-1 and IL-12p40; data not
shown).
Compared to WT Mtb, infection of primary macrophages with
Tn:Rv0431 resulted in secretion of much larger amounts of IL-10,
IL-6, MCP-1, IL-12p40 and TNFa as judged by ELISA and
higher levels of transcripts for GM-CSF and COX-2 as measured
by qRT-PCR (Figure 5D and Figure S3A–B). To confirm that
comparable numbers of bacteria were used for the infection, we
measured the genomic content of each bacterial strain at each of
the three doses administered to macrophages. As shown in
Figure 5D, responses increased in a dose dependent manner for
each strain but Tn:Rv0431 consistently induced more vigorous
responses when comparable bacterial doses were evaluated. This
trend was consistent when responses were regressed against a
Table 1. Identification of Transposon Insertion Site in Mutants with Confirmed Immunoregulatory Phenotypes.
Rv Designation Gene Annotation
Phenotype (Hyper- or
Hypo-Stimulatory
Relative to WT Mtb)
Lipid Metabolism & Trafficking
Rv1146 mmpL13b Transmembrane transport protein Hyper-
Rv0404 fadD30 Long-chain fatty acyl-AMP ligase Hyper-
Rv2928 tesA Thioesterase Hypo-
Rv3087 --- Triacylgleycerol synthase Hypo-
Rv2284 lipM Lipid esterase Hypo-
Rv2051 ppm1 Polyprenol-monophosphomannose synthase Mixed
Rv0017c rodA Cell division protein Hyper-
Secreted Proteins/Secretion Systems
Rv3867 --- Conserved hypothetical =. RD1 locus Hypo-
Rv3869 --- Conserved hypothetical =. RD1 locus Mixed
Rv2608 ppe42 PPE protein Hyper-
Rv3006c lppZ Lipoprotein Mixed
Rv3347c ppe55 PPE protein Hyper-
Transcriptional Regulators
Rv0165c mce1R GNTR-family transcriptional repressor Hypo-
Rv0431 --- Tuberculin-related peptide Hyper-
Intermediary Metabolism
Rv0458 --- Aldehyde Dehydrogenase Hypo-
Rv3549c --- Short-chain type dehydrogenase/reductase Hyper-
Rv0927 --- Short-chain type dehydrogenase/reductase Hyper-
Miscellaneous
Rv1633 uvrB DNA repair enzyme Hyper-
Rv1082 mca Mycothiol conjugate amidase Hyper-
Rv0146 --- SAM-dependent methyltransferase Hyper-
Rv3191 --- Transposase Hypo-
Unannotated --- ORF between Rv3428 and ppe59 Hypo-
Conserved Hypothetical
Rv0264c --- Conserved Hypothetical Hypo-
Rv1590 --- Conserved Hypothetical Hyper-
Rv2307 --- Conserved Hypothetical Hypo-
Rv2082 --- Conserved Hypothetical Hyper-
doi:10.1371/journal.pone.0015120.t001
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PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15120Figure 5. Tn:Rv0431 Dysregulates Macrophage Immunity. (A) Mtb Rv0431 appears in the context of a suite of genes, including Rv0430, sodC,
Rv0433, and Rv0434 which are predicted to be co-transcribed. The members and arrangement of this operon are evolutionarily conserved across
other Mycobacteria and the related Actinobacteria species, Nocardia and Rhodococcus.( B) Average fluorescence induction in IR macrophages by
Tn:Rv0431 (red) or WT Mtb (black) in the number of independent experiments indicated by ‘‘n’’. Data expressed as the average fold-change relative to
induction by WT Mtb 6 SE of replicate wells (C) WT RAW macrophages were infected withTn:Rv0431 (red) or WT Mtb (black). Gene induction was
assessed at 8 hrs post-infection by qRT-PCR. Data are expressed as mean 6 SD of triplicate wells. (D) BMD macrophages were infected with WT Mtb
(black), Tn:Rv0431 (red) or Tn:Rv0431::Rv0431 (blue) over a range of input values (bacterial DNA concentration in pg/mL). TNFa, IL-6, and IL-12p40
were measured in the supernatants by ELISA at 26 hours. Responses in duplicate wells were assessed for each input value. Second-order polynomial
trend lines were fit to the data using Excel.
doi:10.1371/journal.pone.0015120.g005
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(determined by plating the input inoculum on enriched solid
agar; Figure S3C). Importantly, dysregulation was gene specific, as
RANTES, iNOS, and CD40 levels were induced comparably by
both WT and Tn:Rv0431 (Figures S3A–B).
To confirm that disruption of Rv0431 caused the altered
immune responses in macrophages, and to rule out effects due to
secondary mutations, expression of Rv0431 was restored in
Tn:Rv0431 by complementation using the predicted promoter
upstream of Rv0430. As shown in Figure 5D, genetic restoration of
Rv0431 in Tn:Rv0431 fully reverted the immunoregulatory
phenotype to that of WT Mtb.
Finally, we assessed the phenotype of the Tn:Rv0431 mutant in
vivo by exposing C57BL/6 mice to aerosols of Tn:Rv0431 or WT
Mtb. Both strains replicated at comparable rates during the first
week. However, between the first and second week—before the
onset of adaptive immunity detectable with conventional assays—
Tn:Rv0431 became markedly attenuated in the lungs of infected
animals, with CFU an order of magnitude lower than WT at 2
weeks and 2 orders of magnitude lower than WT by 34 weeks
(Figure 6A, B). Genetic complementation of Tn:Rv0431 with the
WT allele restored the bacterial burden to WT levels (Figure 6B).
Infection with Tn:Rv0431 was associated with correspondingly less
gross and microscopic pathology than infection with WT Mtb
(Figure 6C). A similar level of attenuation was noted in the spleens of
Tn:Rv0431-infected animals at later time points (Figure S4A).
Attenuation in vivo was not due to a general growth defect, as
Tn:Rv0431 grew like WT Mtb instandard 7H9 medium (Figure S5).
Differences in cytokine expression in response to infection by
two different strains of Mtb are difficult to interpret when
antigenic load is different. However, the nearly identical bacterial
loads at one week after infection of mice with Tn:Rv0431 or WT
Figure 6. Tn:Rv0431 is Attenuated In Vivo and Elicits Heightened Immune Responses in the Lung. (A) Mice were infected with WT Mtb
(black squares) or Tn:Rv0431 (red squares) via the aerosol route. Bacterial burdens were assessed in the lung at indicated times post-infection. Data
points are means 6 standard deviations from 3–5 mice. Results are representative of 3 independent experiments. (B) As in (A), except
Tn:Rv0431::Rv0431 (blue triangles) was included in this experiment. (C) Gross pathology (right panel) and hematoxylin and eosin staining of lung
sections (406magnification; left panel) from infected animals. Gross pathology images are from the upper left lobes of 3 mice at day 140 post-
infection. Histopathology images are representative sections from the upper left lobes of mice at day 63 post-infection.
doi:10.1371/journal.pone.0015120.g006
Mycobacterial Immunoregulatory Genes
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the lungs at this early time point using qRT-PCR, although levels
were not yet high enough for detection by ELISA. As shown in
Figure S4B, expression of TNFa, IL-6, Lrg-47 and CD40 was
significantly higher in lungs of mice infected with Tn:Rv0431 than
WT Mtb.
Discussion
This study represents one of the most extensive surveys of the
Mtb genome to date to identify factors involved in modulating
macrophage immunity. Many reports have studied single Mtb
genes for their impact on host immunity or multiple Mtb genes for
their immunomodulatory effects on single host genes [22,23,27].
Here, we screened 10,100 Mtb mutants for their impact on
expression of 12 host cytokines, chemokines, enzymes and
developmental regulators. We identified 35 Mtb genes with
previously unknown roles in host immunity and another
228 Mtb genes that are strong candidates for regulating these
host responses. We focused on one gene of unknown function,
Rv0431, and confirmed its profound role in suppressing TNFa,
IL12p40 and IL-6 production in primary macrophages. Mtb
lacking Rv0431 grew normally in vitro but poorly in mice and
thereafter failed to maintain its numbers during the chronic phase
of the infection.
Though important, these findings must be viewed in the context
of the substantial technical challenges associated with a screen of
this breadth and depth, most notably the sensitivity of the
macrophage responses to variations in the bacterial inoculum,
which could not be perfectly normalized across 10,100 mutants.
Nonetheless, despite a large false positive rate in the primary
screen, 68% of the mutants that we subjected to further study were
confirmed to dysregulate innate responses of primary macrophag-
es. Confirmatory analyses are required for the other 228 equally
promising candidates identified in the primary screen that we have
not yet tested in primary macrophages (marked by asterisks in
Tables S1, S2, S3, S4).
With the exception of mceR1 [28], the transposon-disrupted
genes identified in our screen have not been reported to be
involved in immune regulation. However, based on what is known
about the interrupted genes, their homologs in other organisms
and their neighbors on the Mtb chromosome, we consider possible
mechanisms for the observed immunomodulatory properties of
these mutants.
Given that lipids are estimated to contribute .40% of the dry
weight of the bacillus [29], that some are shed [30] and that others
may be among the first molecules on the Mtb surface that
macrophages encounter, it is not surprising that many Mtb lipids
have well-described roles in modulating host immunity, including
phthiocerol dimycoserosates (pDIM), sulfolipids, lipomannans,
mycolic acids and phenolic glycolipids [31,32,33,34]. Many of
the disrupted genes discovered in our screen have predicted roles
in the synthesis, degradation or trafficking of Mtb lipids, including
mmpL13B, tesA, fadD30, Rv3087, lipM, and ppm1. For example,
mmpL13B encodes a putative lipid transporter with homology to
other transporters, such as MmpL7 and MmpL8, known to deliver
immunomodulatory lipids to the cell wall [35,36,37,38,39].
Another identified gene, fadD30, is predicted to encode a long-
chain fatty acyl-AMP ligase involved in lipid synthesis [40].
Deletion of a related enzyme, FadD26, led to a defect in pDIM
production associated with enhanced TNFa and IL-6 secretion
from macrophages [41]. In addition, the gene immediately
downstream of and likely cotranscribed with fadD30, pks6, is
important for polar lipid synthesis [42] and virulence in mice [43],
where it plays a role in countering IFNc-dependent host defenses
[44].
Several other genes we identified could play ancillary roles in
lipid synthesis or storage. tesA, encoding a type II thioesterase, is
located immediately upstream of a large virulence cluster involved
in pDIM biosynthesis and has a postulated role in the release of
mature lipids from the pDIM synthesis machinery [42,45].
Rv3087, codes for a triacylgylcerol synthase within the mymA
operon, which has been linked to virulence, resistance to host
defenses, and the synthesis of mycolic acids, another lipid class
with potent and diverse roles in immunological modulation by
Mtb [27,46,47,48,49,50,51,52,53]. A mutant lacking the mymA
operon induced significantly less IL-1b, IL-6, RANTES, and
MCP-1 in human THP-1 monocyte-like leukemia cells [54],
consistent with our findings of diminished immune responses in
primary mouse macrophages by the Tn:Rv3087 mutant. Ppm1
encodes polyprenol-monophosphomannose synthase, an enzyme
involved in the synthesis of the cell wall glycolipids, lipomannan
and lipoarabinomannan, both of which function as TLR ligands
and as modulators of immune cell function [31].
Several Mtb immunoregulatory genes identified here encode
secreted factors (lppZ, ppe55, and ppe42) or proteins involved in
secretion systems (Rv3867 and Rv3869). Rv3869, and perhaps
Rv3867, function as part of a multi-protein translocon known as
the ESX-1 secretion system, which is involved in the secretion of
virulence and immumodulatory factors, including ESAT-6 and
CFP-10 [55,56,57]. ESX-1-related effects on host immunity
include modulation of inflammation, apoptosis, necrosis, phago-
somal maturation, phagosomal escape, membrane/cell lysis, tissue
invasion, cell-to-cell spread and virulence. The secreted proteins
LppZ, PPE55, and PPE42 are dominant B-cell antigens in
tuberculosis patients [58,59,60]. Other PE/PPE family proteins
are known to modulate cytokine production and apoptosis in T-
cells and macrophages [61,62,63,64,65].
To illustrate the potential of this approach to provide insights
into the immunobiology of experimental tuberculosis, we focused
on Rv0431 because nothing has been reported about this gene, yet
its disruption had a striking effect on macrophage production of
cytokines in vitro and on tuberculosis in the mouse. Disruption of
Rv0431 led to enhanced fluorescence induction in 11 of the 12 IR
macrophage cell clones and robust hyperinflammatory responses
in mutant-infected primary macrophages. In vivo, Tn:Rv0431
became markedly attenuated between day 7 and 14 post-infection
and, at later time points, the reduction in bacterial load was
mirrored by a decrease in accumulation of host lymphoid and
myeloid cells in the lungs. Given that Tn:Rv0431 has no growth
defect in standard broth in vitro, these findings demonstrate a role
for Rv0431 in Mtb virulence. Moreover, attenuation in vivo was
preceded by suggestive evidence for an increased inflammatory
responses in the lung (TNFa, IL-6, TGFb, LRG-47 and CD40)
commonly associated with macrophage or DC responses. The
attenuation of Tn:Rv0431 in vivo is noteworthy in that neither
SodC nor Rv0433 appear to be required for full virulence in mice
[66]. Nevertheless, SodC is markedly upregulated upon infection
of human macrophages and is important for the survival of Mtb in
activated murine macrophages, where it likely functions in the
defense against reactive oxygen species [67,68]. Collectively, these
findings implicate Rv0431 and its neighboring genes as important
Mtb virulence factors and highlight the need for additional studies
to explore the function(s) of this gene cluster.
To our knowledge, this is the first description of a biological role
for Rv0431. Though its cellular function remains unknown, two
short nucleotide stretches in the C-terminus of Rv0431 have low
homology to sequences in other bacterial proteins annotated as cell
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other organisms, LytR-related transcriptional regulators have
important roles in peptidoglycan formation, cell wall maintenance,
biofilm formation, b-lactam resistance and stress tolerance [69,70].
Further study will clarify whether Rv0431 is a transcriptional
regulator.
BCG is the only vaccine now available against tuberculosis but
shows poor efficacy in preventing pulmonary tuberculosis in adults
[71,72]. The limited efficacy of BCG is not surprising, given that
infection with Mtb itself does not routinely lead to protective
immunity against re-infection [3,4,5]. It is a tall order for a vaccine
to generate better immunity than native infection. Most
experimental tuberculosis vaccines use one or two antigens from
Mtb [73]. The work described here is a first step toward testing a
complementary strategy—to subtract a small number of antigens
from Mtb, so that the immune response it elicits is more protective.
After we or others study additional mutants identified in the
present study, it is our hope that mice can be vaccinated with a
single strain engineered to include several such mutations, along
with several that impose auxotrophies to prevent the mutant from
replicating in the host [74].
Materials and Methods
Ethics Statement
Studies with mice followed a protocol approved by the Weill
Cornell Medical College Institutional Animal Care and Use
Committee (#0705-617) and were carried out in strict accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
Mice
Eight-week old female C57BL/6 mice from Jackson Laborato-
ries (Bar Harbor, Maine) were housed in specific-pathogen-free
facilities at Weill Cornell Medical College and Rockefeller
University.
Mycobacterial Cultures
H37Rv Mtb was from ATCC. The mce1 mutant [26] and its
parent strain (Erdman) were kindly provided by S. Ehrt, Weill
Cornell Medical College. The mutant library and Mtb growth in
vitro were as described [25]. Individual mutants were frozen at -80
C in 15% glycerol/7H9 in 96-well plates; library mutants were
thawed and resuspended immediately prior to infection of IR
macrophages, as described below.
Infection of IR Macrophage Clones
IR macrophages were cultured at 37uC with 5% CO2 in
Dulbecco’s Modified Eagle’s Medium supplemented with 10%
heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyru-
vate, and 1 M HEPES (cDMEM). For fluorescence assays, 10
4
total cells were seeded in the inner 60 wells of 96-well microscopy
plates and cultured overnight. For the primary screen, three IR
macrophage clones (each expressing either YFP, DsRed, or
AmCyan) were seeded together in each well and simultaneously
infected with each mutant in the Mtb library. IR macrophages
were treated with 2.5 ng/mL IFNc (Genentech) and infected with
1 mL of each Mtb mutant. Because of differences in bacterial
viability after the freeze-thaw cycle required to store the library,
the actual MOI (as determined by retrospective plating for CFUs
on 7H9 agar) varied considerably across the strains. At 22–24 hrs
post-infection, cells were fixed with 4.2% paraformaldehyde in
PBS for 2 hrs, washed twice with PBS and stained with 2 mg/mL
Hoechst 33342 in PBS. For each round of infection, control wells
on separate plates were studied in medium alone to confirm low
basal fluorescence and after exposure to 2.5 ng/mL IFNc to
confirm responsiveness to a stimulus.
Confirmation of Hits in IR Macrophage Clones
Hits from the primary screen were re-cloned on 7H11/OADC
agar, then grown to early-log phase in 7H9/ADN. Clumps were
removed by centrifugation in PBS-0.05% Tween80 to generate
single-cell suspensions. Bacterial concentration was back-calculat-
ed from OD580 measurements and bacteria were resuspended in
cDMEM for infection of macrophages. Individual (rather than
pooled) IR macrophage clones were infected with each mutant or
WT Mtb at MOI =10 and fluorescence induction was measured
as described above. Mutants that induced $1.4-fold more or
#0.7-fold less fluorescence than WT Mtb were considered
‘‘confirmed’’ with respect to the IR clones and were then tested
in primary macrophages.
Hit Validation in Primary Bone Marrow-Derived (BMD)
Macrophages
BMD were derived as described [12], except antibiotics were
omitted. 10
5 macrophages were infected with single-cell suspen-
sions of pDIM+ WT Mtb or mutant strains at target MOIs of 1, 3
and 5. Tn:Rv0431 and a pDIM-deficient strain were included as
controls for higher and lower induction, respectively. Uninfected
cells served as a negative control. Macrophage responses were
assessed by qRT-PCR at 8 hrs or by ELISA (RnD Systems) at
24 hrs post-infection. Two intra-assay replicates per MOI were
included for every condition and 2–3 independent experiments
were performed for each mutant. Bacterial input was determined
retrospectively by plating serial dilutions on 7H11/OADC agar
and enumerating CFUs.
mRNA Isolation and qRT-PCR
Macrophages were lysed in TRIzol reagent (Invitrogen).
Bromochloropropane was added, then RNA was isolated using
the MagMAX-96 Total RNA Isolation Kit including treatment
with MagMAX TURBO DNase (Ambion). ,300 ng RNA was
reverse transcribed using 50 units MuLV reverse transcriptase,
2.5 mM oligo-d(T)16 primer and 20 units RNase Inhibitor (Applied
Biosystems). mRNA expression levels were evaluated by qRT-
PCR using gene-specific primers and Taqman probes labeled with
FAM and BHQ on the 59- and 39-ends, respectively. Amplifica-
tions were performed on the ABI Prism 7900HT sequence
detection system (PerkinElmer). Threshold values were set in SDS
1.0 software (Applied Biosystems) such that CT values were
derived from the early linear phase. The abundance of gene-
specific mRNAs was quantified relative to expression of the
housekeeping gene GAPDH, according to the formula: Relative
mRNA Induction =2
CT(GAPDH)–CT(GENE).
Identification of Transposon Insertion Sites
Genomic DNA was purified from select mutants and the
transposon insertion site was identified by sequencing.
Mouse Infections
Mice were infected by aerosolizing Mtb suspensions in PBS-
0.05% Tween80 in a Middlebrook airborne infection apparatus
(Glas-col, Terre Haute, Ind.). Mice were euthanatized with CO2
and the right and lower left pulmonary lobes were homogenized in
PBS. Serial dilutions were plated on 7H11/OADC agar for CFU
determination. The upper left lobe was divided for mRNA
extraction and histology (Supplemental Methods).
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Figure S1 Evaluation of IR candidates by fluorescence
microscopy. For each IR line, ,30 clonal populations were
evaluated by fluorescence microscopy for fluorescence induction
under resting or stimulatory conditions. Clones that showed (a)
minimal fluorescence under basal conditions, (b) maximal
induction upon stimulation with IFNc (2.5 ng/mL) or LPS (18
ng/mL), and (c) minimal cell-to-cell heterogeneity among
fluorescent cells, were chosen for use in the primary screen. Three
such clones, from the YFP_IL-10 IR line, are shown here as an
example.
(TIF)
Figure S2 Fluorescence induction is decreased follow-
ing infection with a hypostimulatory Mtb mutant. (A)
Fluorescence induction in the MCP-1_DsRed and IL-6_YFP IR
clones in response to infection with WT (black bars) or mce1-
deficient (red bars) Mtb. Unstimulated cells were included as a
control (grey bar). (B) Secretion of native MCP-1 and IL-6 by WT
RAW264.7 cells in response to infection with WT or mce1-
deficient Mtb, as assessed by ELISA. Data are representative of
two independent experiments. Bars represent mean and standard
deviations of triplicate wells. In experiments measuring IL-6
secretion and IL-6_YFP fluorescence, macrophages were costi-
mulated with 2.5 ng/mL IFNc.
(TIF)
Figure S3 BMD macrophages were infected with WT
Mtb (black) or Tn:Rv0431 (red) over a range of bacterial
inputs. Responses in duplicate wells were assessed for each strain
at each input value. Second-order polynomial trend lines were fit
to the data using Excel. (A) and (B) are from a single representative
experiment in which responses were regressed against bacterial
DNA concentration (ng/uL). (A) Cytokines in the supernatants
were measured by ELISA at 26 hours. (B) Host mRNA expression
was measured by qRT-PCR at 8 hours. (C) As in (A), except that
responses were regressed against the MOI, as determined by
plating for CFUs on enriched solid agar.
(TIF)
Figure S4 Tn:Rv0431 is Attenuated In Vivo and Elicits
Heightened Immune Responses in the Lung. Mice were
infected with WT Mtb (black) or Tn:Rv0431 (red) via the aerosol
route. (A) Bacterial burdens in the spleen at days 14, 28, 63, and
140 post-infection. Data points are means and standard
deviations from 3-5 mice. Results are representative of two
independent experiments. (B) Expression of host genes in the
lungs of infected animals at day 7, as determined by qRT-PCR.
Data are expressed as fold-change relative to responses induced
by WT Mtb. Bars represent the mean and SD from 5 mice.
Asterisk denotes p , 0.05. Results are representative of two
independent experiments.
(TIF)
Figure S5 Tn:Rv0431 Does Not Have a Growth Defect In
Enriched Liquid Culture. WT Mtb (black) and Tn:Rv0431
(red) were grown in 7H9-ADN liquid media for 14 days at 37 C.
The optical density was measured at indicated intervals at 580 nm
as a read-out for culture density.
(TIF)
Table S1 Mutants from the Primary Screen that
Dysregulated One IR Clone with |SR| . 3.5 (Quadrant
I in Figure 2B). Values represent the SR of the response induced
by each mutant (rows) in each of the twelve IR clones (columns) in
the primary screen. SR . 3.5 in red; SR , -3.5 in blue. Mutants
marked by an asterisk were not evaluated in follow-up studies.
(XLS)
Table S2 Mutants from the Primary Screen that
Dysregulated Two IR Clones with an Average |SR| .
3.5 (Quadrant I in Fig 2B). Values represent the SR of the
response induced by each mutant (rows) in each of the twelve IR
clones (columns) in the primary screen. SR . 3.5 in red; 2.0 , SR
, 3.5 in pink; -2.0 . SR . -3.5 in light blue; and SR , -3.5 in
dark blue. The average |SR| (for all responses with |SR| . 2) is
quantified for each mutant in the second column from the right. In
the far right column, ‘‘+’’ denotes a mutant that induced
hyperstimulatory responses, ‘‘–’’ denotes hypostimulatory, and
‘‘M’’ denotes mixed response across IR clones. Mutants marked by
an asterisk were not evaluated in follow-up studies.
(XLS)
Table S3 Mutants from the Primary Screen that
Dysregulated .2 IR Clones with an Average |SR| .
3.5 (Quadrant II in Figure 2B). Values represent the SR of
the responses induced by each mutant in each of the twelve IR
clones in the primary screen. SR . 3.5 in red; 2.0 , SR , 3.5 in
pink; -2.0 . SR . -3.5 in light blue; and SR , -3.5 in dark blue.
The average |SR| (for all responses with |SR| . 2) is quantified
for each mutant. Second column from the right indicates the
number of IR clones with an |SR| . 2.0. In the last column, ‘‘+’’
denotes hyperstimulatory responses, ‘‘–’’ denotes hypostimulatory
responses and ‘‘M’’ denotes mixed responses across IR clones.
Mutants marked by an asterisk were not evaluated in follow-up
studies.
(XLS)
Table S4 Mutants from the Primary Screen that
Dysregulated .2 IR Clones with an Average 2.0 ,
|SR| , 3.5 (Quadrant III in Fig 2B). Values represent the
SR of the responses induced by each mutant in each of the twelve
IR clones in the primary screen. SR . 3.5 in red; 2.0 , SR , 3.5
in pink; -2.0 . SR . -3.5 in light blue; and SR , -3.5 in dark
blue. The average |SR| (for all responses with |SR| . 2) is
quantified for each mutant. Second column from the right
indicates the number of IR clones with an |SR| . 2.0. In the
last column, ‘‘+’’ denotes hyperstimulatory responses, ‘‘–’’ denotes
hypostimulatory responses and ‘‘M’’ denotes mixed responses
across IR clones. Mutants marked by an asterisk were not
evaluated in follow-up studies.
(XLS)
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